title: Anti-inflammatory cytokines, TGF-β1 and IL-10, exert anti-hypoxic action and abolish posthypoxic hyperexcitability in hippocampal slice neurons: comparative aspects.
abstract: The aim of this study was to investigate the comparative effects of transforming growth factor β1 (TGF-β1) and interleukin-10 (IL-10) on the repeated brief hypoxia-induced alterations in the activity of hippocampal slice CA1 pyramidal neurons. The method of field potentials measurement in CA1 region of hippocampal slices was used. The principal results of our work are summarized as follow. 1. TGF-β1 reduces the depressive effect of brief hypoxia on the population spike amplitude more effectively than IL-10. 2. During TGF-β1 exposure (in contrast to IL-10), three 3-min hypoxic episodes do not induce the rapid hypoxic preconditioning. 3. TGF-β1 and IL-10 equally abolish posthypoxic hyperexcitability induced by repeated brief episodes of hypoxia in CA1 pyramidal neurons. These findings indicated that TGF-β1 and IL-10 are able to evoke anti-hypoxic effect and abolish the development of posthypoxic hyperexcitability induced by repeated brief hypoxic episodes in hippocampal CA1 pyramidal neurons. Our results also demonstrated that TGF-β1 reduced the effectiveness of hypoxia to depress neuronal activity more effectively than IL-10. We suggest that the present findings allow to explain the certain neuroprotective mechanisms of IL-10 and TGF-beta1 in the early phase of hypoxia and indicate that a therapeutic anti-inflammatory approach using these substances can provide neuroprotection in the brain hypoxic conditions.
authors.affiliation: Institute of Theoretical and Experimental Biophysics of Russian Academy of Sciences, Pushchino, Moscow Region, 142290, Russia.
authors.forename: Sergei G
authors.initials: SG
authors.lastname: Levin
authors.forename: Oleg V
authors.initials: OV
authors.lastname: Godukhin
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D056547:CA1 Region, Hippocampal / Q000187:drug effects / Q000276:immunology / Q000503:physiopathology; D002534:Hypoxia, Brain / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D016753:Interleukin-10 / Q000494:pharmacology*; D019194:Ischemic Preconditioning / Q000379:methods; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D009924:Organ Culture Techniques; D017966:Pyramidal Cells / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D053773:Transforming Growth Factor beta1 / Q000494:pharmacology*
chemical_list: D000893:Anti-Inflammatory Agents; D053773:Transforming Growth Factor beta1; D016753:Interleukin-10